Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/<b><i>neu</i></b>Transgenic Mice

Elena Quaglino, Manuela Iezzi, Cristina Mastini, +11

Cancer Research

Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells

Michela Spadaro, Cristiana Caorsi, Patrizia Ceruti, +4

The FASEB Journal

Innate Immune SystemImmunologyImmunologic MechanismInnate ImmunityImmune System +16

Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy

Atul Varadhachary, Jeffrey S. Wolf, Karel Petrak, +5

International Journal of Cancer

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

Claudia Curcio, Emma Di Carlo, Raphael Clynes, +9

Journal of Clinical Investigation

Immunosurveillance of<i>Erbb2</i>Carcinogenesis in Transgenic Mice Is Concealed by a Dominant Regulatory T-Cell Self-Tolerance

Elena Ambrosino, Michela Spadaro, Manuela Iezzi, +5

Cancer Research

T-regulatory CellImmunologyImmunotherapyTumor BiologyTumor Immunity +15

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

Elena Quaglino, Simona Rolla, Manuela Iezzi, +11

Journal of Clinical Investigation

PML risk stratification using anti-JCV antibody index and L-selectin

Nicholas Schwab, Tilman Schneider‐Hohendorf, Béatrice Pignolet, +23

Multiple Sclerosis Journal

In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes

Daniela Delli Castelli, Walter Dastrù, Enzo Terreno, +5

Journal of Controlled Release

EngineeringBiomedical ImagingMagnetic ResonanceExtracellular MicrovesiclesIntracellular Trafficking +5

Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity

Michela Spadaro, Elena Ambrosino, Manuela Iezzi, +9

Clinical Cancer Research

A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.

Loredana Cifaldi, Elena Quaglino, Emma Di Carlo, +7

PubMed

ImmunologyImmunoeditingNg Il-12ImmunotherapyCancer Biology +19